Yuhua Ma
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yuhua Ma has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Haisheng He
School of Pharmaceutical Sciences, Fudan University, Key Laboratory of Smart Drug Delivery of MOE and National Key Laboratory of Advanced Drug Formulations for Overcoming Delivery Barriers, Shanghai 201203, China
1 shared publication Jiahui Zou
Department of Pharmaceutics, School of Pharmacy, China Pharmaceutical University, Nanjing 211198, China
1 shared publication- Jiayuan Zhang
Key Laboratory of Smart Drug Delivery of Ministry of Education, School of Pharmacy, Fudan University, Shanghai 201203, China
1 shared publication Jinfeng Zhang
Qinghai Key Laboratory of Phytochemistry in the Qinghai-Xizang Plateau, Qinghai Engineering Research Center of Modern Tibetan Medicine Development, College of Pharmacy, Qinghai Minzu University, Xining 810007, Qinghai, China
1 shared publicationWanting Zhang
Department of Pharmaceutics, School of Pharmacy, China Pharmaceutical University, Nanjing 211198, China
1 shared publication- Wei He
School of Pharmacy, China Pharmaceutical University, Nanjing 211198, China
1 shared publication
Latest Publications
- 25 October 2026
- Vol. 42 (10) , 4355-4370
[Application of cell-penetrating peptides in tumor therapy].
Cell-penetrating peptides (CPPs) represent a class of short peptides capable of efficiently traversing biological membrane barriers, demonstrating substantial potential in tumor-targeted drug delivery. Drugs modified with CPPs can enter cells through direct membrane penetration or endocytic pathways, and CPPs have been extensively investigated in various antitumor drug delivery systems. This review initially categorizes CPPs into cationic peptides, amphipathic peptides, and hydrophobic peptides according to their charge characteristics, and subsequently elucidates the molecular mechanisms underlying CPP-mediated cellular entry. Furthermore, we comprehensively summarize the latest advances in multifunctional nanoplatforms constructed through the integration of CPPs with diverse delivery systems, thereby providing insights for the development of CPP-based antitumor delivery strategies.
- 25 October 2026
- Vol. 42 (10) , 4355-4370
[Application of cell-penetrating peptides in tumor therapy].
Cell-penetrating peptides (CPPs) represent a class of short peptides capable of efficiently traversing biological membrane barriers, demonstrating substantial potential in tumor-targeted drug delivery. Drugs modified with CPPs can enter cells through direct membrane penetration or endocytic pathways, and CPPs have been extensively investigated in various antitumor drug delivery systems. This review initially categorizes CPPs into cationic peptides, amphipathic peptides, and hydrophobic peptides according to their charge characteristics, and subsequently elucidates the molecular mechanisms underlying CPP-mediated cellular entry. Furthermore, we comprehensively summarize the latest advances in multifunctional nanoplatforms constructed through the integration of CPPs with diverse delivery systems, thereby providing insights for the development of CPP-based antitumor delivery strategies.
- 9 October 2025
- Published by Elsevier in Journal of Controlled Release
- Vol. 388 (Pt 1) , 114296
Pulmonary inhaled drug delivery systems: From bench to bedside
- 9 October 2025
- Published by Elsevier in Journal of Controlled Release
- Vol. 388 (Pt 1) , 114296
Pulmonary inhaled drug delivery systems: From bench to bedside
- Open Access
- 5 January 2025
- Published by Elsevier in Asian Journal of Pharmaceutical Sciences
- Vol. 20 (1) , 101015
Polymeric nanocarriers for therapeutic gene delivery
- 5 January 2025
- Published by Elsevier in Asian Journal of Pharmaceutical Sciences
- Vol. 20 (1) , 101015
Open AccessPolymeric nanocarriers for therapeutic gene delivery